ResMed
RMD
S$323.97
Share price
-0.83%
Change (1 day)
17.45%
Change (1 year)
Categories
ResMed (RMD) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$2.59 Billion
According to ResMed's latest financial reports the company's total liabilities are S$2.59 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ResMed - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-06-30 | S$2.72 B | -23.25% |
| 2023-06-30 | S$3.54 B | 46.97% |
| 2022-06-30 | S$2.41 B | -2.64% |
| 2021-06-30 | S$2.47 B | -14.96% |
| 2020-06-30 | S$2.91 B | 5.87% |
| 2019-06-30 | S$2.75 B | 100.9% |
| 2018-06-30 | S$1.36 B | -34.03% |
| 2017-06-30 | S$2.07 B | -1.32% |
| 2016-06-30 | S$2.10 B | 162.68% |
| 2015-06-30 | S$0.80 B | 6.6% |
| 2014-06-30 | S$0.75 B | -1.35% |
| 2013-06-30 | S$0.76 B | 13.37% |
| 2012-06-30 | S$0.67 B | 61.89% |
| 2011-06-30 | S$0.41 B | -11.8% |
| 2010-06-30 | S$0.47 B | -17.07% |
| 2009-06-30 | S$0.56 B | 28.59% |
| 2008-06-30 | S$0.44 B | -10.34% |
| 2007-06-30 | S$0.49 B | 14.91% |
| 2006-06-30 | S$0.42 B | -15.71% |
| 2005-06-30 | S$0.50 B | 57.95% |
| 2004-06-30 | S$0.32 B | 5.8% |
| 2003-06-30 | S$0.30 B | -6.14% |
| 2002-06-30 | S$0.32 B | -5.33% |
| 2001-06-30 | S$0.34 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | S$55.82 B | 2,048.97% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | S$63.70 B | 2,352.43% | 🇺🇸 USA |
 Masimo MASI | S$1.73 B | -33.35% | 🇺🇸 USA |
 Allied Healthcare Products AHPI | S$18.55 M | -99.29% | 🇺🇸 USA |
 Inogen INGN | S$0.14 B | -94.53% | 🇺🇸 USA |
 Philips PHG | S$21.47 B | 726.61% | 🇳🇱 Netherlands |